{"title":"In the Face of New Challenges; Effective Human Factors Engineering for Software as Medical Device Products","authors":"Trine Groenborg","doi":"10.1177/2327857922111021","DOIUrl":null,"url":null,"abstract":"This paper tackles challenges facing human factors professionals when transitioning into working with Software as Medical Device products. Specifically, it outlines the challenges Novo Nordisk A/S has faced when it comes to applying human factors considerations when developing Software as Medical Device products and ensuring regulatory compliance. It showcases the efforts Novo Nordisk A/S has implemented to meet these challenges and conclude on the learnings Novo Nordisk A/S has had with the proposed solutions.","PeriodicalId":74550,"journal":{"name":"Proceedings of the International Symposium of Human Factors and Ergonomics in Healthcare. International Symposium of Human Factors and Ergonomics in Healthcare","volume":"7 1","pages":"104 - 108"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the International Symposium of Human Factors and Ergonomics in Healthcare. International Symposium of Human Factors and Ergonomics in Healthcare","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2327857922111021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This paper tackles challenges facing human factors professionals when transitioning into working with Software as Medical Device products. Specifically, it outlines the challenges Novo Nordisk A/S has faced when it comes to applying human factors considerations when developing Software as Medical Device products and ensuring regulatory compliance. It showcases the efforts Novo Nordisk A/S has implemented to meet these challenges and conclude on the learnings Novo Nordisk A/S has had with the proposed solutions.